On Target Laboratories
Latest round
- Series C
Last raised
- Nov 2023
Total raised
- $95M
Investors
- 8
About On Target Laboratories
Based in the US, On Target Laboratories Inc.Founded in 2010 and headquartered in West Lafayette, Indiana, On Target Laboratories Inc. focuses on creating advanced imaging solutions for surgical teams. The company has undergone no significant pivots or changes in strategy since its inception. Philip Low, a prominent figure in the field of cancer research, is the founder of On Target Laboratories.On Target Laboratories specializes in the development of targeted intraoperative molecular imaging agents, primarily focusing on its flagship product, CYTALUX. This FDA-approved imaging agent binds to cancerous tissue, enhancing the visibility of lesions during surgical procedures. By illuminating the tumor sites in real-time, CYTALUX empowers surgeons to detect and excise more cancerous cells, thereby improving surgical outcomes for patients. The company's core clientele includes healthcare providers, particularly surgical teams and oncology specialists, who rely on advanced imaging technology to optimize cancer treatments.On Target Laboratories generates revenue through direct transactions with healthcare institutions and surgical facilities that utilize its imaging technology in operating rooms. The company’s business model is structured around the sale of its CYTALUX imaging agents, which are supplied on a per-procedure basis to surgical teams. This transactional approach allows healthcare providers to procure the necessary amounts as required for specific surgeries, facilitating cost-effective use of advanced technology. Payments are processed through institutional purchasing agreements, with ongoing partnerships as hospitals integrate these imaging solutions into their surgical practices.In November 2023, On Target Laboratories Inc. The company plans to expand its reach into new geographic regions, focusing on international markets with a strategy to enter by 2025.
Who invested in On Target Laboratories
8 investors across 4 rounds
See all investors in On Target Laboratories
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about On Target Laboratories
Who invested in On Target Laboratories?
On Target Laboratories has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has On Target Laboratories raised?
On Target Laboratories has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did On Target Laboratories last raise money?
On Target Laboratories's most recent round on record is a Series C, in Nov 2023.
What does On Target Laboratories do?
Based in the US, On Target Laboratories Inc.
Where is On Target Laboratories headquartered?
On Target Laboratories is headquartered in West Lafayette, US.
Which VCs invest in companies like On Target Laboratories?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at On Target Laboratories's stage. Their profiles are linked below.
VCs backing healthcare startups at Series C
Raising like On Target Laboratories? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.